Harrow Q2 2026 revenue $70.7M, up 60% sequentially; reiterates FY guidance

HARROW, INC.

Q2 2026 revenue $70.7M, up 60% sequentially and 11% Y/Y; net loss $17.3M vs income $5.0M a year ago
VEVYE revenue $29.4M, up ~40% sequentially and ~58% Y/Y; TRx share 14.6% vs 7.8% a year ago
IHEEZO unit demand record 65,477 units, up 44% sequentially; net price improved ~25% effective July 1, 2026
Announced acquisition of TYRVAYA from Viatris; expected to close H2 2026, contribute >$30M revenue in 2027
Reiterated FY2026 guidance: revenue $350M-$365M and Adjusted EBITDA $80M-$100M

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.